Cytocentrics
San Antonio, US · Founded 2014 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
JR
James R. GarvinChief Executive Officer, President, Secretary and Treasurer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.5MraisedMar 2018 · 3 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMar 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan DeanDirector
- Paul CastellaDirector
- James R. GarvinExecutive Officer, Director
- Ian ClementsDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Sales commissions
- $90K
- Proceeds to insiders
- $250K
- Placement agents
- Divine Capital Markets
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$15.8MraisedJan 2018 · 11 investors · BiotechnologyRule 506(b)
▶$15.8MraisedJan 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ian ClementsDirector
- James R. GarvinExecutive Officer, Director
- Alan DeanDirector
- Paul CastellaDirector
- Offering amount
- $21.8M
- Amount sold
- $15.8M
- Sales commissions
- $137.5K
- Placement agents
- Divine Capital Markets LLC
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶Undisclosed amountofferedMar 2015 · 2 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedMar 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James R. GarvinExecutive Officer, Director
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.